Safety Study of a Sensitive Sensual Touch and Personal Lubricant
NCT ID: NCT01271036
Last Updated: 2014-03-04
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
124 participants
INTERVENTIONAL
2010-12-31
2011-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Safety Evaluation of Personal Lubricant Product When Used by Couples in Home-use Conditions
NCT00779025
Safety Study for an All-in-One Body and Personal Lubricant
NCT01189617
A Clinical Study to Evaluate the Safety of a Personal Lubricant in Healthy Female Subjects
NCT02737592
In-Home Use Study to Evaluate Use of an Intimate Health Product in Females
NCT00778934
Clinical Study to Prove Safety in Use (Irritability and Sensitization in Genital Mucosa) of an Intimate Lubricating Gel
NCT02441647
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Formula PD-F-7716
Apply a dime-size amount on each application site as instructed during the 1-week study period
Formula PD-F-7716
Apply a dime-size amount on each application site as instructed during the 1-week study period
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Formula PD-F-7716
Apply a dime-size amount on each application site as instructed during the 1-week study period
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Subjects comfortable discussing sensitive topics such as personal hygiene, menstruation and sexuality
* At least one partner in the couple has sensitive skin per protocol-defined criteria
* Able to read and understand English
* Voluntarily signs an Informed Consent document after the trial has been explained
* Willing to follow all study procedures, including birth control requirements
Exclusion Criteria
* Participation as a research subject within timelines dictated by protocol
* Participants with relationships or employment outside protocol-defined parameters
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Johnson & Johnson Healthcare Products Division of McNEIL-PPC, Inc.
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Sherryl Frisch
Role: STUDY_DIRECTOR
Johnson & Johnson Consumer and Personal Products Worldwide
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Thomas J Stephens & Associates, Inc.
Colorado Springs, Colorado, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
KOYNAP0010
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.